- Description
- Table of Contents
- Request Sample
The Global Sickle Cell Anemia Therapeutics market is expected to reach $5,567.75 million by 2026 growing at a CAGR of 12.5% during the forecast period. Sickle-cell anaemia is a disease which is categorized by the existence of sickle-shaped erythrocytes. Sickle-cell anaemia is an inherited, lifelong blood disorder that impacts haemoglobin causing serious damage to the body. Some of the key factors driving the growth of sickle-cell anaemia therapeutics market are the unmet medical needs and the increase in sickle-cell diseases. However, the side effects associated with current therapies and low awareness among individuals will surely impede the growth of this market. Based on the Product Type, the pharmacotherapy segment is estimated to have a lucrative growth due to the potential launch of promising pipeline candidates such as Voxelotor, Crizanlizumab, Rivipansel, and Altemia. It is also estimated to lead the market, owing to a strong pipeline and several promising drug launches throughout the forecast period. The key vendors mentioned are Addmedica, Baxter, Bioverativ, Bluebird Bio, Bristol-Myers, Squibb, Daiichi Sankyo, Eli Lilly, Emmaus Medical, Gamida Cell, Gilead Sciences, Global Blood Therapeutics, GlycoMimetics, HemaQuest Pharmaceuticals, Imara, Ironwood Pharmaceuticals, Johnson & Johnson, Mast Therapeutics, Merck Sharp & Dohme, Micelle BioPharma, and Modus Therapeutics. Medications Covered: • Antibiotics • Hydroxyurea • Pain-Relieving Medications • Folic Acids • Antimetabolites • Vaccines • Analgesics • Other Medications Therapies Covered: • Hydroxyurea • L-Glutamine Product Types Covered: • Blood Transfusion • Bone Marrow Transplant • Gene Therapy • Pharmacotherapy Applications Covered: • Adult • Child End Users Covered: • Government • Home Healthcare • Hospitals • Infusion Centers • Private Clinics • Other End Users Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Sickle Cell Anemia Therapeutics Market, By Medication
5.1 Introduction
5.2 Antibiotics
5.3 Hydroxyurea
5.4 Pain-Relieving Medications
5.5 Folic Acids
5.6 Antimetabolites
5.7 Vaccines
5.8 Analgesics
5.9 Other Medications
6 Global Sickle Cell Anemia Therapeutics Market, By Therapy
6.1 Introduction
6.2 Hydroxyurea
6.3 L-Glutamine
7 Global Sickle Cell Anemia Therapeutics Market, By Product Type
7.1 Introduction
7.2 Blood Transfusion
7.3 Bone Marrow Transplant
7.4 Gene Therapy
7.5 Pharmacotherapy
8 Global Sickle Cell Anemia Therapeutics Market, By Application
8.1 Introduction
8.2 Adult
8.3 Child
9 Global Sickle Cell Anemia Therapeutics Market, By End User
9.1 Introduction
9.2 Government
9.3 Home Healthcare
9.4 Hospitals
9.5 Infusion Centers
9.6 Private Clinics
9.7 Other End Users
10 Global Sickle Cell Anemia Therapeutics Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Addmedica
12.2 Baxter
12.3 Bioverativ
12.4 Bluebird Bio
12.5 Bristol-Myers Squibb
12.6 Daiichi Sankyo
12.7 Eli Lilly
12.8 Emmaus Medical
12.9 Gamida Cell
12.10 Gilead Sciences
12.11 Global Blood Therapeutics
12.12 GlycoMimetics
12.13 HemaQuest Pharmaceuticals
12.14 Imara
12.15 Ironwood Pharmaceuticals
12.16 Johnson & Johnson
12.17 Mast Therapeutics
12.18 Merck Sharp & Dohme
12.19 Micelle BioPharma
12.20 Modus Therapeutics
List of Data Tables
Table 1 Global Sickle Cell Anemia Therapeutics Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 3 Global Sickle Cell Anemia Therapeutics Market Outlook, By Antibiotics (2016-2026) ($MN)
Table 4 Global Sickle Cell Anemia Therapeutics Market Outlook, By Hydroxyurea (2016-2026) ($MN)
Table 5 Global Sickle Cell Anemia Therapeutics Market Outlook, By Pain-Relieving Medications (2016-2026) ($MN)
Table 6 Global Sickle Cell Anemia Therapeutics Market Outlook, By Folic Acids (2016-2026) ($MN)
Table 7 Global Sickle Cell Anemia Therapeutics Market Outlook, By Antimetabolites (2016-2026) ($MN)
Table 8 Global Sickle Cell Anemia Therapeutics Market Outlook, By Vaccines (2016-2026) ($MN)
Table 9 Global Sickle Cell Anemia Therapeutics Market Outlook, By Analgesics (2016-2026) ($MN)
Table 10 Global Sickle Cell Anemia Therapeutics Market Outlook, By Other Medications (2016-2026) ($MN)
Table 11 Global Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 12 Global Sickle Cell Anemia Therapeutics Market Outlook, By Hydroxyurea (2016-2026) ($MN)
Table 13 Global Sickle Cell Anemia Therapeutics Market Outlook, By L-Glutamine (2016-2026) ($MN)
Table 14 Global Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 15 Global Sickle Cell Anemia Therapeutics Market Outlook, By Blood Transfusion (2016-2026) ($MN)
Table 16 Global Sickle Cell Anemia Therapeutics Market Outlook, By Bone Marrow Transplant (2016-2026) ($MN)
Table 17 Global Sickle Cell Anemia Therapeutics Market Outlook, By Gene Therapy (2016-2026) ($MN)
Table 18 Global Sickle Cell Anemia Therapeutics Market Outlook, By Pharmacotherapy (2016-2026) ($MN)
Table 19 Global Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 20 Global Sickle Cell Anemia Therapeutics Market Outlook, By Adult (2016-2026) ($MN)
Table 21 Global Sickle Cell Anemia Therapeutics Market Outlook, By Child (2016-2026) ($MN)
Table 22 Global Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)
Table 23 Global Sickle Cell Anemia Therapeutics Market Outlook, By Government (2016-2026) ($MN)
Table 24 Global Sickle Cell Anemia Therapeutics Market Outlook, By Home Healthcare (2016-2026) ($MN)
Table 25 Global Sickle Cell Anemia Therapeutics Market Outlook, By Hospitals (2016-2026) ($MN)
Table 26 Global Sickle Cell Anemia Therapeutics Market Outlook, By Infusion Centers (2016-2026) ($MN)
Table 27 Global Sickle Cell Anemia Therapeutics Market Outlook, By Private Clinics (2016-2026) ($MN)
Table 28 Global Sickle Cell Anemia Therapeutics Market Outlook, By Other End Users (2016-2026) ($MN)
Table 29 North America Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 30 North America Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 31 North America Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 32 North America Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 33 North America Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)
Table 34 Europe Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 35 Europe Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 36 Europe Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 37 Europe Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 38 Europe Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)
Table 39 Asia Pacific Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 40 Asia Pacific Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 41 Asia Pacific Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 42 Asia Pacific Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 43 Asia Pacific Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)
Table 44 South America Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 45 South America Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 46 South America Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 47 South America Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 48 South America Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)
Table 49 Middle East & Africa Sickle Cell Anemia Therapeutics Market Outlook, By Medication (2016-2026) ($MN)
Table 50 Middle East & Africa Sickle Cell Anemia Therapeutics Market Outlook, By Therapy (2016-2026) ($MN)
Table 51 Middle East & Africa Sickle Cell Anemia Therapeutics Market Outlook, By Product Type (2016-2026) ($MN)
Table 52 Middle East & Africa Sickle Cell Anemia Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 53 Middle East & Africa Sickle Cell Anemia Therapeutics Market Outlook, By End User (2016-2026) ($MN)